Vanda Pharmaceuticals Inc. (VNDA) — Net Income

Annual figures by fiscal year, from SEC filings.

2009: -$35.86M2010: $7.19M2011: -$9.80M2012: -$28.62M2013: -$21.05M2014: $20.19M2015: -$39.87M2016: -$18.01M2017: -$15.57M2018: $25.21M2019: $115.55M2020: $23.34M2021: $33.15M2022: $6.28M2023: $2.51M2024: -$18.90M2025: -$220.47M-$220.47M
2009Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$220.47M-1066.5%
2024-$18.90M-853.3%
2023$2.51M-60.0%
2022$6.28M-81.1%
2021$33.15M+42.1%
2020$23.34M-79.8%
2019$115.55M+358.4%
2018$25.21M+261.9%
2017-$15.57M+13.6%
2016-$18.01M+54.8%
2015-$39.87M-297.5%
2014$20.19M+195.9%
2013-$21.05M+26.4%
2012-$28.62M-192.0%
2011-$9.80M-236.3%
2010$7.19M+120.1%
2009-$35.86M